Sigma Labs, Inc. | ||||||||||
Statement of Stockholders' Equity | ||||||||||
For The Twelve Months Ended December 31, 2018 and the Year Ended December 31, 2017 | ||||||||||
Common Stock
Shares |
Common Stock
Amount |
Additional Paid
in Capital |
Accumulated
Deficit | Totals | ||||||
Balance December 31, 2016 | 3,133,789 | $ | 3,135 | $ | 10,734,857 | $ | -9,760,954 | $ | 977,038 | |
Shares issued for Services at a price of $1.72 | 20,000 | 20 | 34,384 | 34,404 | ||||||
Shares issued for Services at a price of $3.25 | 5,232 | 5 | 16,999 | 17,004 | ||||||
Shares issued for Services at a price of $2.27 | 7,489 | 7 | 16,993 | 17,000 | ||||||
Shares issued for Services at a price of $2.07 | 8,213 | 8 | 16,992 | 17,000 | ||||||
Shares sold in Dawson & James Offering at a net price of $3.757 | 1,410,000 | 1,410 | 4,885,811 | 4,887,221 | ||||||
Warrants sold in Dawson & James Offering at a price of $0.13 | 183,300 | 183,300 | ||||||||
Warrents sold at a price of $.01 | 2,115 | 2,115 | ||||||||
Debt discount on notes payable | - | - | 0 | - | 0 | |||||
Shares Issued from exercise of Warrants | 141,000 | 141 | -141 | - | 0 | |||||
Shares forfeited | -8,250 | -8 | -9,822 | - | -9,830 | |||||
Fractional shares issued at reverse stock split | 1,178 | 1 | - | - | 1 | |||||
Shares Issued for Note Payables Conversions | 200,000 | 200 | 399,800 | 400,000 | ||||||
Shares Issued for Accrued Interest on Noter Payable (L1) | 4,278 | 4 | 8,552 | 8,556 | ||||||
Shares Issued from exercise of Warrants (L1) | 56,000 | 56 | 111,944 | 112,000 | ||||||
Writeoff of Derivative Liability upon note conversions | 280,114 | 280,114 | ||||||||
Stock options awarded to employees | 510,496 | 510,496 | ||||||||
Net loss for the twelve months ended December 31, 2017 | -4,424,503 | -4,424,503 | ||||||||
Balance December 31, 2017 | 4,978,929 | $ | 4,979 | $ | 17,192,394 | $ | -14,185,457 | $ | 3,011,916 | |
Shares issued for Services at a price of $1.72 | 23,256 | 23 | 39,977 | - | 40,000 | |||||
Shares issued for Services at a price of $1.2236 | 176,744 | 177 | 216,087 | - | 216,264 | |||||
Convertible Preferred Shares issued in PIPE | - | - | 877,499 | 877,499 | ||||||
Shares issued for Conversion of Preferred | 1,000,000 | 1,000 | -999 | - | 1 | |||||
Preferred Dividends Paid upon Conversion | -15,125 | -15,125 | ||||||||
Shares Issued for Note Payables Conversions | 25,000 | 25 | 49,975 | - | 50,000 | |||||
Shares Issued for Cashless Exchange of Warrants | 4,800 | 5 | -5 | - | 0 | |||||
Shares sold in DJames Public Offering at a net price of $0.895 | 2,040,000 | 2,040 | 1,720,360 | - | 1,722,400 | |||||
Series C Convertible Preferred Shares Issued | 346,500 | 346,500 | ||||||||
Shares issued for Conversion of Preferred | 350,000 | 350 | -350 | - | 0 | |||||
Shares Issued from exercise of Warrants | 177,900 | 178 | 191,954 | - | 192,132 | |||||
Stock options awarded to employees | - | - | 868,015 | - | 868,015 | |||||
Net loss for the Twelve months ended December 31, 2018 | 0 | 0 | 0 | -5,574,163 | -5,574,163 | |||||
Balance December 31, 2018 | 8,776,629 | $ | 8,777 | $ | 21,501,407 | $ | -19,774,745 | $ | 1,735,438 | |
Sigma Labs Announces Full Year 2018 Financial Results
| | More MCAD News |
|
RELATED NEWS